Medicover AB (publ)

OM:MCOV B Stock Report

Market Cap: SEK 28.7b

Medicover Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Fredrik Rågmark

Chief executive officer

€2.7m

Total compensation

CEO salary percentage39.2%
CEO tenure27.9yrs
CEO ownership1.0%
Management average tenure3.5yrs
Board average tenure15.4yrs

Recent management updates

Recent updates

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Dec 12
Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07
The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24
Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22
Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04
Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11
Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Dec 20
Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Dec 02
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Sep 12
Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Aug 21
Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12
Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27
Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12
Is Medicover (STO:MCOV B) Using Too Much Debt?

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16
Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30
Is Medicover (STO:MCOV B) Using Too Much Debt?

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30
Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17
Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30
Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16
Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Sep 09
Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Jul 25
Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Jul 12
Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Jun 13
Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

May 29
At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

CEO Compensation Analysis

How has Fredrik Rågmark's remuneration changed compared to Medicover's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

€20m

Jun 30 2024n/an/a

€23m

Mar 31 2024n/an/a

€22m

Dec 31 2023€3m€1m

€18m

Sep 30 2023n/an/a

€8m

Jun 30 2023n/an/a

€5m

Mar 31 2023n/an/a

€1m

Dec 31 2022€3m€1m

€12m

Sep 30 2022n/an/a

€37m

Jun 30 2022n/an/a

€59m

Mar 31 2022n/an/a

€88m

Dec 31 2021€2m€952k

€102m

Sep 30 2021n/an/a

€93m

Jun 30 2021n/an/a

€90m

Mar 31 2021n/an/a

€52m

Dec 31 2020€2m€670k

€26m

Sep 30 2020n/an/a

€14m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€16m

Dec 31 2019€1m€900k

€23m

Sep 30 2019n/an/a

€19m

Jun 30 2019n/an/a

€19m

Mar 31 2019n/an/a

€20m

Dec 31 2018€1m€807k

€22m

Sep 30 2018n/an/a

€28m

Jun 30 2018n/an/a

€26m

Mar 31 2018n/an/a

€23m

Dec 31 2017€921k€810k

€19m

Compensation vs Market: Fredrik's total compensation ($USD2.81M) is above average for companies of similar size in the Swedish market ($USD908.09K).

Compensation vs Earnings: Fredrik's compensation has been consistent with company performance over the past year.

CEO

Fredrik Rågmark (61 yo)

27.9yrs

Tenure

€2,707,000

Compensation

Mr. Fredrik Ragmark serves as the Chief Executive Officer of Medicover AB (publ). Mr. Ragmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär AB.Fr...

Leadership Team

NamePositionTenureCompensationOwnership
Fredrik Rågmark
CEO & Directorno data€2.71m1.04%
SEK 299.0m
Anand Patel
Chief Financial Officerless than a yearno datano data
Jaroslaw Urbanczyk
Chief Information Officer5.2yrsno data0.0052%
SEK 1.5m
Hanna Bjellquist
Head of Investor Relationsno datano datano data
Jenny Brandt
General Legal Counselno datano data0.031%
SEK 8.9m
Andrew Vallance-Owen
Chief Marketing Officerno datano datano data
Kamila Skorupinski
Group Chief People Officerless than a yearno datano data
John Stubbington
Chief Operating Officer of Healthcare Services8.8yrsno data0.53%
SEK 152.0m
Staffan Ternstrom
Chief Operating Officer for Diagnostic Services3.5yrsno data0.035%
SEK 10.1m

3.5yrs

Average Tenure

57.5yo

Average Age

Experienced Management: MCOV B's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Fredrik Rågmark
CEO & Director27.9yrs€2.71m1.04%
SEK 299.0m
Robert Jochnick
Independent Director17.9yrs€54.60k1.21%
SEK 347.9m
Fredrik Stenmo
Independent Chairman19.9yrs€101.50k4.41%
SEK 1.3b
Margareta Nordenvall
Independent Director23.9yrs€66.20k0.060%
SEK 17.2m
Arno Bohn
Independent Director23.9yrs€63.05k0.20%
SEK 57.4m
Cecil Michael Flemming
Independent Director9.9yrs€78.30kno data
Anne Berner
Independent Director2.7yrs€59.85kno data
Azita Shariati
Independent Director2.7yrs€63.05k0.0015%
SEK 422.0k
Peder Jochnick
Independent Director12.9yrs€54.60k2.59%
SEK 742.7m
Sonali Chandmal
Independent Director7.9yrs€71.45k0.017%
SEK 4.8m

15.4yrs

Average Tenure

60.5yo

Average Age

Experienced Board: MCOV B's board of directors are seasoned and experienced ( 15.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 11:44
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicover AB (publ) is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Lars HevrengDanske Bank
James Alexander Vane-TempestJefferies LLC